Larvol Delta - BioAge-Labs-Presents-Preclinical-Data-for-Apelin-Receptor-Agonist-Azelaprag-for-Obesity-Demonstrating-Signicant-Improvements-in-Weight-Loss-and-Body-Composition-When-Combined-with-Incretin-Drugs

azelaprag (BGE-105) - BioAge Labs

https://www.businesswire.com/news/home/20240621663769/en/BioAge-Labs-Presents-Preclinical-Data-for-Apelin-Receptor-Agonist-Azelaprag-for-Obesity-Demonstrating-Significant-Improvements-in-Weight-Loss-and-Body-Composition-When-Combined-with-Incretin-Drugs

Jun 21, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next